Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction TPF + CCRT vs CCRT in NPC
NCT01245959Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2011
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of docetaxel, cisplatin and fluorouracil in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Failure-free survival at 3 years. Status: unknown.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01245959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01245959.